{"AllianceGenome": "4077", "HGNC": "4077", "MIM": "305660", "_id": "2556", "_version": 1, "accession": {"genomic": ["AC108171.3", "AC116666.2", "AF282854.4", "AH009803.2", "CH471169.1", "CP068255.2", "KF459470.1", "KF459486.1", "KF459487.1", "KF459488.1", "KF459489.1", "KF459490.1", "KF459491.1", "KF459492.1", "KF459493.1", "KF459494.1", "NC_000023.11", "NC_060947.1", "NG_007102.2"], "protein": ["AAB27279.1", "AAG12455.1", "AAH28629.1", "BAG35318.1", "CAA01919.1", "EAW99423.1", "NP_000799.1", "P34903.1", "XP_006724874.1", "XP_054182733.1"], "rna": ["A28102.1", "AK312404.1", "BC028629.1", "DA402645.1", "KJ620007.1", "MW585264.1", "MW585265.1", "MW585266.1", "MW585267.1", "MW585268.1", "MW585269.1", "MW585270.1", "MW585271.1", "MW585272.1", "MW585273.1", "MW585274.1", "MW585275.1", "MW585276.1", "MW585277.1", "MW585278.1", "MW585279.1", "MW585280.1", "MW585281.1", "MW585282.1", "MW585283.1", "MW585284.1", "NM_000808.4", "S62908.1", "XM_006724811.4", "XM_054326758.1"], "translation": [{"protein": "NP_000799.1", "rna": "NM_000808.4"}, {"protein": "CAA01919.1", "rna": "A28102.1"}, {"protein": "XP_006724874.1", "rna": "XM_006724811.4"}, {"protein": "AAB27279.1", "rna": "S62908.1"}, {"protein": "BAG35318.1", "rna": "AK312404.1"}, {"protein": "AAH28629.1", "rna": "BC028629.1"}, {"protein": "XP_054182733.1", "rna": "XM_054326758.1"}]}, "alias": "EPILX2", "ensembl": {"gene": "ENSG00000011677", "protein": ["ENSP00000359337", "ENSP00000443527"], "transcript": ["ENST00000370314", "ENST00000417858", "ENST00000497894", "ENST00000535043"], "translation": [{"protein": "ENSP00000359337", "rna": "ENST00000370314"}, {"protein": "ENSP00000443527", "rna": "ENST00000535043"}], "type_of_gene": "protein_coding"}, "entrezgene": "2556", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 11.90334723, "exp_mis": 118.2160783, "exp_syn": 49.471932, "lof_z": 2.55628016522806, "mis_z": 2.66390000298296, "mu_lof": 1.09782691638e-06, "mu_mis": 1.47330035793e-05, "mu_syn": 5.91619960092e-06, "n_lof": 3.0, "n_mis": 59.0, "n_syn": 39.0, "p_li": 0.273213945815421, "p_null": 0.00517157873655736, "p_rec": 0.721614475448021, "syn_z": 0.922989478703839}, "bp": 1479, "cds_end": 151533042, "cds_start": 151336699, "n_exons": 9, "nonpsych": {"exp_lof": 10.6574833, "exp_mis": 107.0875822, "exp_syn": 44.7337637, "lof_z": 2.30361918057945, "mis_z": 2.68501035581917, "mu_lof": 1.09782691638e-06, "mu_mis": 1.47330035793e-05, "mu_syn": 5.91619960092e-06, "n_lof": 3.0, "n_mis": 52.0, "n_syn": 35.0, "p_li": 0.211577412350307, "p_null": 0.0109178866695509, "p_rec": 0.777504700980142, "syn_z": 0.916276345235439}, "nontcga": {"exp_lof": 10.79443544, "exp_mis": 107.6226998, "exp_syn": 45.01141875, "lof_z": 2.34026982614949, "mis_z": 2.76726964771638, "mu_lof": 1.09782691638e-06, "mu_mis": 1.47330035793e-05, "mu_syn": 5.91619960092e-06, "n_lof": 3.0, "n_mis": 50.0, "n_syn": 36.0, "p_li": 0.204667426485694, "p_null": 0.00961422293817086, "p_rec": 0.785718350576135, "syn_z": 0.850460537319071}, "transcript": "ENST00000370314.4"}, "exons": [{"cdsend": 152364570, "cdsstart": 152168227, "chr": "X", "position": [[152166233, 152168563], [152189729, 152189941], [152197632, 152197785], [152208000, 152208144], [152224762, 152224845], [152255777, 152255998], [152284667, 152284735], [152345580, 152345702], [152364430, 152364596], [152451145, 152451315]], "strand": -1, "transcript": "NM_000808", "txend": 152451315, "txstart": 152166233}], "exons_hg19": [{"cdsend": 151533042, "cdsstart": 151336699, "chr": "X", "position": [[151334705, 151337035], [151358201, 151358413], [151366104, 151366257], [151376472, 151376616], [151393234, 151393317], [151424249, 151424470], [151453139, 151453207], [151514052, 151514174], [151532902, 151533068], [151619617, 151619787]], "strand": -1, "transcript": "NM_000808", "txend": 151619787, "txstart": 151334705}], "generif": [{"pubmed": 11140838, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 11378843, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11602034, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11840313, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14751442, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15033447, "text": "extracellular domain models show subunit arrangement of GABA-A receptors"}, {"pubmed": 15048654, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15048654, "text": "The results of our study indicate that GABRA 3 gene might also be involved in the genetic pathophysiology of unipolar major depressive disorder"}, {"pubmed": 17970773, "text": "3 of GABRA3 are found to be associated with THPP"}, {"pubmed": 17970773, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18085588, "text": "In the SNr GABA(A) receptors contain alpha(1), alpha(3), beta(2,3), and gamma(2) subunits and are localized in a weblike network over the cell soma, dendrites, and spines of SNr parvalbumin-positive nonpigmented neurons."}, {"pubmed": 18334916, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18821008, "text": "Data show that GABRA3 is significant reductions in parietal cortex in subjects with autism."}, {"pubmed": 19048400, "text": "GABRA3 gene was overexpressed in lung cancer and rarely expressed in other cancers"}, {"pubmed": 19058789, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19078961, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19084931, "text": "GABA and GABRA3 play important roles in hepatocellular carcinoma (HCC) development and progression and can be a promising molecular target for the development of new diagnostic and therapeutic strategies for HCC."}, {"pubmed": 19086053, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19842164, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19842164, "text": "These findings suggest that common variation in the GABRA2, GABRA3, GABRA6, and GABRG2 genes does not play a major role in liability to anxiety spectrum disorders."}, {"pubmed": 19874574, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20351714, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20468064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20692323, "text": "The ratios of beta(3)/beta(2) and alpha(5)/alpha(1) subunit protein expression in Angelman syndrome cortex were significantly decreased when compared with controls."}, {"pubmed": 20843900, "text": "In subjects with schizophrenia, GABA A alpha3 receptor expression is 14% higher in layer 2 of the dorsolateral prefrontal cortex."}, {"pubmed": 21971078, "text": "The results indicate that there may be specific GABA receptor gene expression variation in migraine, particularly involving the GABRA3 and GABBR2 genes."}, {"pubmed": 23169495, "text": "We identified truncating mutations in distinct X-linked gamma-aminobutyric acid A (GABAA) receptor subunit-encoding genes, GABRQ and GABRA3.this is the first report of ASD patients with truncating mutations in GABA receptors genes."}, {"pubmed": 23617850, "text": "high expression of GABBR2 with a low expression of GABR(A3) may predict a better outcome in non-small cell lung cancer"}, {"pubmed": 23727119, "text": "Endogenous potentiation of GABAergic synaptic transmission and responses to GABA uncaging in the thalamic reticular nucleus is absent in mice in which benzodiazepine binding to alpha3 subunit-containing GABAARs is disrupted."}, {"pubmed": 24055488, "text": "A novel role for GA-repeat core promoter to regulate gene expression in the genes such as GABRA3 involved in development and evolution."}, {"pubmed": 25531214, "text": "The N-terminal region of GABRA3 and the GlyR beta subunit occupies the same binding site of gephyrin."}, {"pubmed": 26518133, "text": "The alpha3-immunoreactivity in the cerebellar cortex was relatively weak, but it was abundantly observed in different cell populations in the subcortical cerebellar structures"}, {"pubmed": 26869349, "text": "Gabra3 activates the AKT pathway to promote breast cancer cell migration, invasion and metastasis. The A-to-I RNA-edited form of Gabra3 is found only in non-invasive breast cancers. Edited Gabra3 suppresses breast cancer cell invasion and metastasis."}, {"pubmed": 27081042, "text": "GABRA3 induced MMP-2 and MMP-9 expression through activation of the JNK/AP-1 signaling pathway, promoting lymphatic metastasis in lung adenocarcinoma."}, {"pubmed": 27128218, "text": "GABA alpha2 and/or alpha3 receptor subtypes are involved in GABAergic modulation of prolactin secretion."}, {"pubmed": 27412533, "text": "These small-molecule GlyR PAMs have high potential both as early tool compounds to enable pharmacological studies of GlyR inhibitory neurotransmission and as a starting point for the development of potent, selective GlyRalpha3 PAMs as novel analgesics."}, {"pubmed": 29023704, "text": "The GABRA3 found distribute in intercalated nucleui of amygdala and dentate gyrus."}, {"pubmed": 29053855, "text": "Five missense variants and one microduplication were detected in four families and two sporadic cases presenting with a range of epileptic seizure types, a varying degree of intellectual disability and developmental delay, sometimes with dysmorphic features or nystagmus."}, {"pubmed": 31593956, "text": "data indicate that the activation of CT-GABRA3 is correlated with that of MAGEA6. Therefore, MAGEA6 is linked with CT-GABRA3 through a bidirectional promoter."}, {"pubmed": 31610743, "text": "The intracellular domain of GABRA3 and GABRB3 each contain essential anterograde trafficking signals that are required to overcome ER retention of assembled GABAA homo- or heteropentamers."}, {"pubmed": 31841197, "text": "MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients."}], "genomic_pos": {"chr": "X", "end": 152451315, "ensemblgene": "ENSG00000011677", "start": 152166234, "strand": -1}, "genomic_pos_hg19": {"chr": "X", "end": 151619830, "start": 151334706, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0007214", "qualifier": "involved_in", "term": "gamma-aminobutyric acid signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007214", "qualifier": "involved_in", "term": "gamma-aminobutyric acid signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0051932", "qualifier": "involved_in", "term": "synaptic transmission, GABAergic"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060078", "qualifier": "involved_in", "term": "regulation of postsynaptic membrane potential"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:1902476", "qualifier": "involved_in", "term": "chloride transmembrane transport"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:1904862", "qualifier": "involved_in", "term": "inhibitory synapse assembly"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0032590", "qualifier": "is_active_in", "term": "dendrite membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0034707", "qualifier": "part_of", "term": "chloride channel complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043005", "qualifier": "is_active_in", "term": "neuron projection"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0045202", "qualifier": "is_active_in", "term": "synapse"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0045211", "qualifier": "located_in", "term": "postsynaptic membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0098794", "qualifier": "is_active_in", "term": "postsynapse"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:1902495", "qualifier": "part_of", "term": "transmembrane transporter complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:1902711", "qualifier": "part_of", "term": "GABA-A receptor complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:1902711", "qualifier": "part_of", "term": "GABA-A receptor complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004890", "qualifier": "contributes_to", "term": "GABA-A receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004890", "pubmed": 16412217, "qualifier": "enables", "term": "GABA-A receptor activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004890", "qualifier": "enables", "term": "GABA-A receptor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005254", "qualifier": "contributes_to", "term": "chloride channel activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 26613940, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008503", "qualifier": "contributes_to", "term": "benzodiazepine receptor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0022851", "qualifier": "enables", "term": "GABA-gated chloride ion channel activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0022851", "pubmed": 16412217, "qualifier": "enables", "term": "GABA-gated chloride ion channel activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0022851", "pubmed": 29053855, "qualifier": "enables", "term": "GABA-gated chloride ion channel activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0022851", "qualifier": "enables", "term": "GABA-gated chloride ion channel activity"}]}, "homologene": {"genes": [[7165, 1270594], [7227, 39984], [8364, 100494398], [9031, 422289], [9544, 711230], [9606, 2556], [9615, 492223], [9913, 282237], [10090, 14396], [10116, 24947]], "id": 20218}, "interpro": [{"desc": "Gamma-aminobutyric-acid A receptor, alpha subunit", "id": "IPR001390", "short_desc": "GABAAa_rcpt"}, {"desc": "Gamma-aminobutyric-acid A receptor, alpha 3 subunit", "id": "IPR005433", "short_desc": "GABBAa3_rcpt"}, {"desc": "Gamma-aminobutyric acid A receptor/Glycine receptor alpha", "id": "IPR006028", "short_desc": "GABAA/Glycine_rcpt"}, {"desc": "Neurotransmitter-gated ion-channel transmembrane domain", "id": "IPR006029", "short_desc": "Neurotrans-gated_channel_TM"}, {"desc": "Neurotransmitter-gated ion-channel", "id": "IPR006201", "short_desc": "Neur_channel"}, {"desc": "Neurotransmitter-gated ion-channel ligand-binding domain", "id": "IPR006202", "short_desc": "Neur_chan_lig-bd"}, {"desc": "Neurotransmitter-gated ion-channel, conserved site", "id": "IPR018000", "short_desc": "Neurotransmitter_ion_chnl_CS"}, {"desc": "Neurotransmitter-gated ion-channel transmembrane domain superfamily", "id": "IPR036719", "short_desc": "Neuro-gated_channel_TM_sf"}, {"desc": "Neurotransmitter-gated ion-channel ligand-binding domain superfamily", "id": "IPR036734", "short_desc": "Neur_chan_lig-bd_sf"}, {"desc": "Neuronal acetylcholine receptor", "id": "IPR038050", "short_desc": "Neuro_actylchol_rec"}, {"desc": "Gamma-aminobutyric acid receptor subunit alpha 1-6, transmembrane domain", "id": "IPR047024", "short_desc": "Gabra-1-6_TM"}], "ipi": "IPI00002897", "map_location": "Xq28", "name": "gamma-aminobutyric acid type A receptor subunit alpha3", "other_names": ["GABA(A) receptor subunit alpha-3", "GABA(A) receptor, alpha 3", "GABAAR subunit alpha-3", "gamma-aminobutyric acid (GABA) A receptor, alpha 3", "gamma-aminobutyric acid receptor subunit alpha-3", "gamma-aminobutyric acid type A receptor alpha3 subunit", "gamma-animobutyric acid (GABA) A receptor, alpha 3"], "pantherdb": {"HGNC": "4077", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95615", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 10090, "uniprot_kb": "P26049"}, {"RGD": "2648", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 10116, "uniprot_kb": "P20236"}, {"Ensembl": "ENSGALG00000007269", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 9031, "uniprot_kb": "F1NAX6"}, {"ZFIN": "ZDB-GENE-091204-365", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 7955, "uniprot_kb": "A0A2R8QC15"}, {"WormBase": "WBGene00008551", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "Q6BET0"}, {"WormBase": "WBGene00013914", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 6239, "uniprot_kb": "G5ECN1"}, {"FlyBase": "FBgn0030707", "ortholog_type": "O", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "Q9VXL9"}, {"FlyBase": "FBgn0001134", "ortholog_type": "LDO", "panther_family": "PTHR18945", "taxid": 7227, "uniprot_kb": "Q24352"}], "uniprot_kb": "P34903"}, "pathway": {"biocarta": [{"id": "flumazenilpathway", "name": "cardiac protection against ros"}, {"id": "gabapathway", "name": "gamma-aminobutyric acid receptor life cycle pathway"}], "kegg": [{"id": "hsa04080", "name": "Neuroactive ligand-receptor interaction - Homo sapiens (human)"}, {"id": "hsa04723", "name": "Retrograde endocannabinoid signaling - Homo sapiens (human)"}, {"id": "hsa04727", "name": "GABAergic synapse - Homo sapiens (human)"}, {"id": "hsa04742", "name": "Taste transduction - Homo sapiens (human)"}, {"id": "hsa05032", "name": "Morphine addiction - Homo sapiens (human)"}, {"id": "hsa05033", "name": "Nicotine addiction - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-977443", "name": "GABA receptor activation"}, {"id": "R-HSA-977443", "name": "GABA receptor activation"}], "wikipathways": [{"id": "WP4159", "name": "GABA receptor Signaling"}, {"id": "WP4312", "name": "Rett syndrome causing genes"}, {"id": "WP4829", "name": "mBDNF and proBDNF regulation of GABA neurotransmission"}]}, "pfam": ["PF02931", "PF02932"], "pharmgkb": "PA28491", "pharos": {"target_id": 12631, "tdl": "Tclin"}, "pir": "I77911", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF249695", "relationship": "is"}, {"id": "GNF249696", "relationship": "is"}, {"id": "GNF249697", "relationship": "is"}, {"id": "GNF249698", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF162859", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF050295", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082986", "relationship": "is"}, {"id": "GNF082987", "relationship": "is"}, {"id": "GNF082988", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054150", "relationship": "is"}, {"id": "GNF058930", "relationship": "is"}, {"id": "GNF074229", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF067741", "relationship": "is"}, {"id": "GNF067742", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF283150", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF284077", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF005631", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094356", "relationship": "is"}, {"id": "GNF134013", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1", "NG_007102.2"], "protein": ["NP_000799.1", "XP_006724874.1", "XP_054182733.1"], "rna": ["NM_000808.4", "XM_006724811.4", "XM_054326758.1"], "translation": [{"protein": "NP_000799.1", "rna": "NM_000808.4"}, {"protein": "XP_006724874.1", "rna": "XM_006724811.4"}, {"protein": "XP_054182733.1", "rna": "XM_054326758.1"}]}, "reporter": {"HG-U133_Plus_2": "207210_at", "HG-U95Av2": "31726_at", "HTA-2_0": "TC0X001493.hg.1", "HuEx-1_0": "4026075", "HuGene-1_1": "8175696", "HuGene-2_1": "17115014"}, "summary": "GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008].", "symbol": "GABRA3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414910"}, "unigene": "Hs.123024", "uniprot": {"Swiss-Prot": "P34903"}, "wikipedia": {"url_stub": "GABRA3"}}